A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options

Abstract

Tight junction and epithelial barrier disruption is a common trait of many gastrointestinal pathologies, including chemotherapy-induced gut toxicity. Currently, there are no validated in vitro models suitable for the study of chemotherapy-induced mucosal damage that allow paralleled functional and structural analyses of tight junction integrity. We therefore aimed to determine if a transparent, polyester membrane insert supports a polarized T84 monolayer with the phenotypically normal tight junctions. T84 cells (passage 5–15) were seeded into either 0.6 cm², 0.4 µm pore mixed-cellulose transwell hanging inserts or 1.12 cm², 0.4 µm pore polyester transwell inserts at varying densities. Transepithelial electrical resistance was measured daily to assess barrier formation. Immunofluoresence for key tight junction proteins (occludin, zonular occludens-1, claudin-1) and transmission electron microscopy were performed to assess tight junction integrity, organelle distribution, and polarity. Reverse transcription-polymerase chain reaction was performed to determine expression of toll-like receptor 4 (TLR4). Liquid chromatography was also conducted to assess SN38 degradation in this model. Polyester membrane inserts support a polarized T84 phenotype with functional tight junctions in vitro. Transmission electron microscopy indicated polarity, with apico-laterally located tight junctions. Immunofluorescence showed membranous staining for all tight junction proteins. No internalization was evident. T84 cells expressed TLR4, although this was significantly lower than levels seen in HT29 cells (P = .0377). SN38 underwent more rapid degradation in the presence of cells (−76.04 ± 1.86%) compared to blank membrane (−48.39 ± 4.01%), indicating metabolic processes. Polyester membrane inserts provide a novel platform for paralleled functional and structural analysis of tight junction integrity in T84 monolayers. T84 cells exhibit the unique ability to metabolize SN38 as well as expressing TLR4, making this an excellent platform to study clinically relevant therapeutic interventions for SN38-induced mucosal damage by targeting TLR4.

Keywords

transwell support barrier function tight junctions SN38 toll-like receptor 4

Get full access to this article

View all access options for this article.

References

Melichar

Dvorak

Krcmova

Hyspler

Urbanek

Solichova

. Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea. Am J Clin Oncol 2008; 31(6): 580–84.

Ley

Peterson

Gordon

. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124(4): 837–48.

Hollander

. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1999; 1(5): 410–16.

Donato

El-Merhibi

Gundsambuu

Mak

Formosa

Wang

Abbott

Powell

. Studying permeability in a commonly used epithelial cell line: T84 intestinal epithelial cells. Methods Mol Biol 2011; 763, 115–37.

Wardill

Bowen

. Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions. Curr Opin Support Palliat Care 2013; 7(2): 155–61.

Schulzke

Ploeger

Amasheh

Fromm

Zeissig

Troeger

Richter

Bojarski

Schumann

Fromm

. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009; 1165, 294–300.

Cummins

. Occludin: one protein, many forms. Mol Cell Biol 2012; 32(2): 242–50.

Keefe

Cummins

Dale

Kotasek

Robb

Sage

. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 1997; 92(4): 385–89.

Wardill

Bowen

Al-Dasooqi

Sultani

Bateman

Stansborough

Shirren

Gibson

. Irinotecan disrupts tight junction proteins within the gut: implications for chemotherapy-induced gut toxicity. Cancer Biol Ther 2013; 15(2): 8–8.

10.

Wardill HR, Logan RM, Bowen JM, Van Sebille YZ, Gibson RJ. Tight junction defects are seen in the buccal mucosa of patients recieveing standard dose chemotherapy for cancer. Support Care Cancer: Official J Multinational Assoc Support Care Cancer 2015;24: 1779–1788.

11.

Wardill

Bowen

Gibson

. Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal? Cancer Chemother Pharmacol 2012; 70(5): 627–35.

12.

Umezawa

Kiba

Numata

Saito

Nakaoka

Shintani

Sekihara

. Comparisons of the pharmacokinetics and the leukopenia and thrombocytopenia grade after administration of irinotecan and 5-fluorouracil in combination to rats. Anticancer Res 2000; 20(6B): 4235–42.

13.

Gibson

Bowen

Alvarez

Finnie

Keefe

. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 2007; 53(5): 360–69.

14.

Araki

Ishikawa

Iigo

Koide

Itabashi

Hoshi

. Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11. Jpn J Cancer Res: Gann 1993; 84(6): 697–702.

15.

Pedroso

Vieira

Bastos

Oliveira

Cartelle

Arantes

Soares

Generoso

Cardoso

Teixeira

Nicoli

Martins

. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiology 2015; 161, 1950–1960.

16.

Dharmsathaphorn

McRoberts

Mandel

Tisdale

Masui

. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 1984; 246(2 Pt 1): G204–08.

17.

Cartwright

McRoberts

Mandel

Masui

Dharmsathaphorn

. Electrolyte transport in a human colonic cell line: regulation by cAMP and calcium. Kroc Found Ser 1984; 17, 65–75.

18.

Gonzalez-Mariscal

Tapia

Chamorro

. Crosstalk of tight junction components with signaling pathways. Biochimica et biophysica acta 2008; 1778(3): 729–56.

19.

Cummins

. Occludin: one protein, many forms. Mol Cell Biol 2012; 32(2): 242–50.

20.

Chiba

Kojima

Osanai

Sawada

. The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci STKE 2006; 2006(316): pe1–pe1.

21.

Edelblum

Turner

. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 2009; 9(6): 715–20.

22.

Gao

Zhao

Zhou

Jiang

Zhang

. VEGI attenuates the inflammatory injury and disruption of blood-brain barrier partly by suppressing the TLR4/NF-kappaB signaling pathway in experimental traumatic brain injury. Brain Res 2015; 1622, 230–39.

23.

Jiang

Qin

Han

. Primary breast cancer induces pulmonary vascular hyperpermeability and promotes metastasis via the VEGF-PKC pathway. Mol Carcinog 2015. Epub ahead of print 8 July 2015. DOI: 10.1002/mc.22352.

24.

Nassour

Dubreuil

. Escherichia coli STb enterotoxin dislodges claudin-1 from epithelial tight junctions. PloS One 2014; 9(11): e113273–e113273.

25.

Staff

. Correction: Escherichia coli STb enterotoxin dislodges claudin-1 from epithelial tight junctions. PloS One 2015; 10(3): e0118983–e0118983.

26.

Hamada

Kakigawa

Sekine

Shitara

Horie

. Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis. Cancer Chemother Pharmacol 2013; 72(4): 757–65.

27.

Bala

Rao

Boyd

Prestidge

. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. Jo Control Release 2013; 172(1): 48–61.

28.

Salphati

Plise

. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513. Eur J Pharm Sci 2009; 37(3–4): 463–68.

29.

Pfrunder

Gutmann

Beglinger

Drewe

. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 2003; 55(1): 59–66.

30.

Naruhashi

Kurahashi

Fujita

Kawakita

Yamasaki

Hattori

Nishimura

Shibata

. Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics. Drug Metab Pharmacokinet 2011; 26(2): 145–53.

31.

Hsu

Chan

Spicer

Rousseau

Giannias

Rousseau

Ferri

. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis. Cancer Res 2011; 71(5): 1989–98.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB